Los Angeles

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Celgene2 trials

Running trials

• Active, not recruiting

  An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

  NCT04717414· Phase 3· Celgene· Source

Closed trials

• Terminated

  Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

  NCT03440372· Phase 3· Celgene· Source